A multivariate approach for the simultaneous determination of losartan potassium and hydrochlorothiazide in a combined pharmaceutical tablet formulation

Maggio, Rubén M.; Castellano, Patricia M.; Kaufman, Teodoro S.
August 2008
Analytical & Bioanalytical Chemistry;Aug2008, Vol. 391 Issue 8, p2949
Academic Journal
A convenient new method for the simultaneous determination of losartan potassium and hydrochlorothiazide, with minimum sample pretreatment, is described. The procedure, based on the multivariate analysis of spectral data in the 220−274 nm region by the partial least squares algorithm, is linear in the concentration range 1.06−5.70 mg L−1 for hydrochlorothiazide and 4.0−22.2 mg L−1 for losartan. It is simple, rapid and robust, allowing accurate and precise results, with drug recovery rates of 99.3 and 100.4% and relative standard deviations of 1.7 and 1.0% obtained for hydrochlorothiazide and losartan, respectively. The method was applied to the simultaneous determination of both analytes in tablets, and it provided good results which were in statistical agreement with those provided by independent HPLC analyses of the samples. The method has also been successfully applied for the construction of drug dissolution profiles of a commercial pharmaceutical preparation containing both analytes. [Figure not available: see fulltext.]


Related Articles

  • Development and Validation of Simultaneous HPLC method for Estimation of Telmisartan and Ramipril in Pharmaceutical Formulations. Jawla, Sunil; Jeyalakshmi, K.; Krishnamurthy, T.; Kumar, Y. // International Journal of PharmTech Research;Apr2010, Vol. 2 Issue 2, p1625 

    A simple isocratic HPLC method has been developed and subsequently validated for simultaneous determination of Telmisartan and Ramipril in pharmaceutical dosage forms. The method employs an Inertsil ODS C18 column, 5 μ, 250 mm x 4.60 mm id with flow rate of 1.5 ml/min using PDA detection at...

  • Simultaneous Determination of Telmisartan Impurities and Chlorthalidone impurities by UPLC. Marineni, Brahmaiah; Sreenivasulu Reddy, T. // International Journal of Pharmaceutical Sciences Review & Resear;May/Jun2014, Vol. 26 Issue 2, p226 

    A rapid specific UPLC method has been developed for simultaneous determination of Telmisartan (TS) impurities and Chlorthalidone (CT) impurities in their formulations. Chromatographic separation of these two compounds impurities was carried out an Acquity BEH Shield-RP18, 100 x 2.1 mm, 1.7 μm...

  • The vasodilatory action of telmisartan on isolated mesenteric artery rings from rats. Xiao-ping Chen; Li-ren Qian // Iranian Journal of Basic Medical Sciences;Oct2015, Vol. 18 Issue 10, p974 

    Objective(s): Angiotensin II type 1 receptor blockers (ARBs) represent one of the widely used antihypertensive agents. In addition to anti-hypertension effect, some ARBs also show other molecular effects such as activating peroxisome proliferator-activated receptor-y and so on. Here we studied...

  • Responses to angiotensin II antagonist before and after treatment with indomethacin in Bartter's syndrome. Sasaki, Haruka; Okumura, Makoto; Asano, Takashi; Arakawa, Kikuo; Kawasaki, Terukazu // British Medical Journal;10/15/1977, Vol. 2 Issue 6093, p995 

    Investigates the responses to angiotensin II antagonist following the treatment of Bartter's syndrome with indomethacin. Role of intrinsic angiotensin II in blood pressure control; Impairments associated with the syndrome; Increase in body weight; Decrease in the serum total protein concentration.

  • Development and Validation of Multi-Component Mode UV Spectrophotometric Method for the Estimation of Telmisartan and Amlodipine besylate in Combined Dosage Form. Maheshwari, Shishir; Srivastav, Atul // Asian Journal of Research in Chemistry;Oct2013, Vol. 6 Issue 10, p973 

    A simple, sensitive, precise and specific UV spectrophotometric method for Multicomponent Mode of Amlodipine besylate and Telmisartan in combine dosage form has been developed. The wavelengths 238 nm and 295 nm were selected for estimation of Amlodipine besylate and Telmisartan respectively,...

  • The effects of Losartan on oxidative stress and inflammation in non-diabetic patients undergoing chronic hemodialysis. KAYABASI, H.; YILMAZ, Z.; SIT, D.; KADIROGLU, A. K.; YILMAZ, E. // European Review for Medical & Pharmacological Sciences;Jan2013, Vol. 17 Issue 2, p235 

    INTRODUCTION: We aimed to evaluate the effects of Losartan, an angiotensin receptor blocker, on serum inflammatory markers, plasma thiol groups, and oxidative stress indexes among patients undergoing hemodialysis (HD) treatment. PATIENTS AND METHODS: Fifty-two end-stage renal disease (ESRD)...

  • Losartan.  // Reactions Weekly;3/15/2008, Issue 1193, p20 

    The article describes the case of a 55-year-old man with psoriasis who developed bullous pemphigoid after losartan was initiated for a hypertensive crisis. The patient had hyperlipidaemia, and psoriasis vulgaris that was previously treated with ciclosporin and UV therapy. He received losartan...

  • Design and Evaluation of Transdermal Delivery System Containing Losartan Potassium. Aparna, Pisipati; Bhadrayya, Kalva; Subrahmanyam, Chavali Venkata Satya // Journal of Pharmacy Research;2012, Vol. 5 Issue 8, p4443 

    In the present study matrix type transdermal patches of losartan potassium (LP) were prepared using hydrophobic polymers, polymethylmethacrylate (PMMA), ethyl cellulose (EC) using solvent evaporation technique. Polyethylene glycol 400 (14% w/w) and dimethyl sulphoxide (DMSO 7% w/w) were used....

  • Telmisartan/Hydrochlorothiazide. Ripley, Betsy // Drugs;2003, Vol. 63 Issue 19, p2027 

    Comments on the use of telmisartan/hydrochlorothiazide in controlling hypertension. Combination of a selective angiotensin II receptor antagonist and a thiazide-type diuretic; Advantages of a dual and synergistic mechanism; U.S. Food and Drug Administration's approval of the combination drug as...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics